Skip to content

To explore the application of VR technology in the management of acute pain in patients with fractures

To explore the application of VR technology in the management of acute pain in patients with fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107080
Enrollment
Unknown
Registered
2025-08-04
Start date
2025-08-06
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of bone

Interventions

Test group:The intervention was conducted by using analgesic drugs combined with VR glasses to watch pain management courses for 30 minutes. The course included pain cognitive education, physical and
Control group:Analgesic drugs combined with non-drug intervention method was adopted, that is, nurses and patients were given face to face health education guidance, including pain cognitive education

Sponsors

General Hospital of Western Theater Command of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. A single fracture caused by various reasons with acute pain; 2. Conservative treatment; 3. age >=18 years old; 4. no obvious language and consciousness disorders, able to cooperate with the research; 5. Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1. visual and hearing impairment; 2. patients with life-threatening injuries, such as massive bleeding, respiratory obstruction and pneumothorax; 3. History of epilepsy or other mental disorders; 4. severe eye diseases, such as glaucoma and retinopathy; 5. patients with motion sickness; 6. History of drug abuse.

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Secondary

MeasureTime frame
SAS Anxiety Scale;

Countries

China

Contacts

Public ContactWang Yonghua

General Hospital of Western Theater Command of PLA

2906624225@qq.com+86 191 5030 3094

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026